Stay updated on ABP798 vs Rituximab in NHL: Clinical Trial
Sign up to get notified when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.

Latest updates to the ABP798 vs Rituximab in NHL: Clinical Trial page
- Check7 days agoChange DetectedSite revision updated to v3.5.2.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedPadua, Italy, 35128 was replaced with Padova, Italy, 35128 in the Locations section.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.4.2 was added, replacing v3.4.1, indicating a minor update. This does not modify study content, eligibility criteria, or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check80 days agoChange DetectedThe IPD Sharing section now lists Revision: v3.4.1, replacing v3.4.0, indicating a document version update.SummaryDifference0.0%

Stay in the know with updates to ABP798 vs Rituximab in NHL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP798 vs Rituximab in NHL: Clinical Trial page.